2012
DOI: 10.1016/j.steroids.2012.01.020
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and antileukemic activity of 16E-[4-(2-carboxy)ethoxybenzylidene]-androstene amides

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
15
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 18 publications
(15 citation statements)
references
References 16 publications
(23 reference statements)
0
15
0
Order By: Relevance
“…The failure of conventional chemotherapeutic agents to yield anticipated results in most of the cases has compelled to discover innovative agents with cancer selectivity [1]. Several 16E-arylidene androstene derivatives with varying degree of antineoplastic activity have been reported from our laboratory [2,3]. Our previous studies indicate that changing the substituents at C 16 of the steroid skeleton can generate tissue selective anticancer compounds.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…The failure of conventional chemotherapeutic agents to yield anticipated results in most of the cases has compelled to discover innovative agents with cancer selectivity [1]. Several 16E-arylidene androstene derivatives with varying degree of antineoplastic activity have been reported from our laboratory [2,3]. Our previous studies indicate that changing the substituents at C 16 of the steroid skeleton can generate tissue selective anticancer compounds.…”
Section: Introductionmentioning
confidence: 99%
“…Our previous studies indicate that changing the substituents at C 16 of the steroid skeleton can generate tissue selective anticancer compounds. Presence of tertiary amino groups through a 16-arylidene group at the C 16 position as well as replacement or substitution of C 3 -OH function has a prominent impact on potency as well as selectivity of this class of cytotoxic steroids [2]. The molecular hybridization strategy, in which pharmacologically crucial structural elements from two prototype molecules are combined to produce a non-identical twin drug, is employed as a rational drug design approach.…”
Section: Introductionmentioning
confidence: 99%
“…It was found that introducing heterocycles into steroids, [7][8][9][10][11][12] by modification of the steroidal side chain or substitution of the steroidal skeleton, can result in a change in its biological activities. [13][14][15][16][17] Steroids containing heteroatoms have been widely researched and reported.…”
Section: Introductionmentioning
confidence: 99%
“…It was found that introducing heterocycles into steroids, [7][8][9][10][11][12] by modification of the steroidal side chain or substitution of the steroidal skeleton, introducing a heteroatom or replacing one or more carbon atoms in steroidal molecule with a heteroatom, can result in a change in its biological activities. [13][14][15][16][17] Steroids containing heteroatoms have been widely researched and reported.…”
Section: Introductionmentioning
confidence: 99%